WRITING NEW FUTURES

Serial Number 98602094
730

Registration Progress

Application Filed
Jun 14, 2024
Under Examination
Jul 1, 2025
Approved for Publication
May 6, 2025
Published for Opposition
May 6, 2025
Registered

Attorney Assistance

NOA E-Mailed - SOU Required
Due: Jul 01, 2026 191 days

Trademark Image

WRITING NEW FUTURES

Basic Information

Serial Number
98602094
Filing Date
June 14, 2024
Published for Opposition
May 6, 2025
Drawing Code
4

Status Summary

Current Status
Active
Status Code
730
Status Date
Dec 8, 2025
Application
Pending
Classes
005 035 044 045

Rights Holder

BioMarin Pharmaceutical Inc.

03
Address
105 Digital Drive
Novato, CA 94949

Ownership History

BioMarin Pharmaceutical Inc.

Original Applicant
03
Novato, CA

BioMarin Pharmaceutical Inc.

Owner at Publication
03
Novato, CA

Legal Representation

Attorney
Gregory J. Chinlund

USPTO Deadlines

Next Deadline
191 days remaining
NOA E-Mailed - SOU Required
Due Date
July 01, 2026
Extension Available
Until January 01, 2027

Application History

22 events
Date Code Type Description Documents
Dec 9, 2025 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Dec 8, 2025 EX1G S SOU EXTENSION 1 GRANTED Loading...
Dec 8, 2025 EXT1 S SOU EXTENSION 1 FILED Loading...
Dec 8, 2025 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jul 1, 2025 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
May 6, 2025 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
May 6, 2025 PUBO A PUBLISHED FOR OPPOSITION Loading...
Apr 30, 2025 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Apr 3, 2025 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Apr 3, 2025 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Apr 3, 2025 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Apr 3, 2025 GNEA F EXAMINERS AMENDMENT E-MAILED Loading...
Apr 3, 2025 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Feb 3, 2025 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Feb 3, 2025 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Feb 3, 2025 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Nov 21, 2024 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Nov 21, 2024 GNRT F NON-FINAL ACTION E-MAILED Loading...
Nov 21, 2024 CNRT R NON-FINAL ACTION WRITTEN Loading...
Sep 30, 2024 DOCK D ASSIGNED TO EXAMINER Loading...
Jun 14, 2024 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Jun 14, 2024 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations for use in enzyme therapy; pharmaceutical preparations for use in treatment of genetic disorders
Class 035
Maintaining patient medical records and files
Class 044
Medical information; Providing health information; Providing medical information in the field of rare diseases; Providing on-line information, news and commentary in the field of health and wellness relating to rare diseases; Providing information to patients in the field of administering medications; Prescription refill reminder services
Class 045
Providing patient advocate and case management services, namely, coordinating the procurement and administration of medication; Investigation services related to insurance claims; Providing live, one-on-one personal support services for patients and families of patients with rare diseases, namely, providing counseling and support, and making personal arrangements for health care

Classification

International Classes
005 035 044 045